Attardi L D, Jacks T
Center for Cancer Research, Massachusetts Institute of Technology, Cambridge 02139, USA.
Cell Mol Life Sci. 1999 Jan;55(1):48-63. doi: 10.1007/s000180050269.
The use of mouse models has greatly contributed to our understanding of the role of p53 in tumour suppression. Mice homozygous for a deletion in the p53 gene develop tumours at high frequency, providing essential evidence for the importance of p53 as a tumour suppressor. Additionally, crossing these knockout mice or transgenic expression p53 dominant negative alleles with other tumour-prone mouse strains has allowed the effect of p53 loss on tumour development to be examined further. In a variety of mouse models, absence of p53 facilitates tumorigenesis, thus providing a means to study how the lack of p53 enhances tumour development and to define genetic pathways of p53 action. Depending on the particular model system, loss of p53 either results in deregulated cell-cycle entry or aberrant apoptosis (programmed cell death), confirming results found in cell culture systems and providing insight into in vitro function of p53. Finally, as p53 null mice rapidly develop tumours, they are useful for evaluating agents for either chemopreventative or therapeutic activities.
小鼠模型的使用极大地促进了我们对p53在肿瘤抑制中作用的理解。p53基因缺失的纯合小鼠高频发生肿瘤,为p53作为肿瘤抑制因子的重要性提供了关键证据。此外,将这些基因敲除小鼠或表达p53显性负性等位基因的转基因小鼠与其他易患肿瘤的小鼠品系杂交,使得能够进一步研究p53缺失对肿瘤发生的影响。在多种小鼠模型中,p53的缺失促进肿瘤发生,从而提供了一种手段来研究p53缺失如何增强肿瘤发展以及确定p53作用的遗传途径。根据特定的模型系统,p53的缺失要么导致细胞周期进入失控,要么导致异常凋亡(程序性细胞死亡),这证实了在细胞培养系统中发现的结果,并为p53的体外功能提供了深入了解。最后,由于p53基因敲除小鼠会迅速发生肿瘤,它们可用于评估具有化学预防或治疗活性的药物。